Scholarlink

<p>Silver nanoparticles (AgNP) are extensively used in consumer and medical products, making systemic exposure increasingly plausible. Once in circulation, AgNP directly interact with erythrocytes; however, AgNP effects on human erythrocytes remain poorly characterised, despite the central role of erythrocytes in maintaining blood homeostasis and the likelihood of direct nanoparticle contact following human exposure. Quercetin, a dietary flavonoid with potent antioxidant and anti-inflammatory activities, has shown cytoprotective potential against oxidative damage in various cell types, but its ability to counteract AgNP-induced erythrotoxicity has not yet been established. Accordingly, we (i) evaluated the effects of citrate-coated AgNP of 5, 10, and 50&#xa0;nm on human erythrocytes and (ii) investigated the potential protective role of quercetin against AgNP-induced toxicity. The results showed that all citrate-coated AgNP induced haemolysis in human erythrocytes. Exposure to all three nanoparticle sizes markedly increased intracellular levels of pro-oxidant reactive species (RS). In particular, 10 and 50&#xa0;nm AgNP caused a significant decrease in total glutathione (GSH) levels. Additionally, all tested AgNP also induced ATP decrease. Moreover, the 5 and 10&#xa0;nm AgNP increased intracellular calcium levels. Remarkably, pre-treatment with quercetin conferred protection against almost all tested cytotoxic endpoints. However, quercetin failed to prevent total GSH loss and even exacerbated ATP depletion. Collectively, these findings provide the first integrated evidence of three sizes of AgNP-induced toxicity in human erythrocytes, demonstrating that quercetin confers broad, though not universal, protection. This underscores its potential as a modulator of nanoparticle-induced oxidative and metabolic damage.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Quercetin mitigates size-dependent oxidative and metabolic toxicity of citrate-coated silver nanoparticles in human erythrocytes

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月17日

查看全文
  • Inês Santos,
  • Vera M. Costa,
  • Félix Carvalho,
  • Eduarda Fernandes,
  • Marisa Freitas

摘要

Silver nanoparticles (AgNP) are extensively used in consumer and medical products, making systemic exposure increasingly plausible. Once in circulation, AgNP directly interact with erythrocytes; however, AgNP effects on human erythrocytes remain poorly characterised, despite the central role of erythrocytes in maintaining blood homeostasis and the likelihood of direct nanoparticle contact following human exposure. Quercetin, a dietary flavonoid with potent antioxidant and anti-inflammatory activities, has shown cytoprotective potential against oxidative damage in various cell types, but its ability to counteract AgNP-induced erythrotoxicity has not yet been established. Accordingly, we (i) evaluated the effects of citrate-coated AgNP of 5, 10, and 50 nm on human erythrocytes and (ii) investigated the potential protective role of quercetin against AgNP-induced toxicity. The results showed that all citrate-coated AgNP induced haemolysis in human erythrocytes. Exposure to all three nanoparticle sizes markedly increased intracellular levels of pro-oxidant reactive species (RS). In particular, 10 and 50 nm AgNP caused a significant decrease in total glutathione (GSH) levels. Additionally, all tested AgNP also induced ATP decrease. Moreover, the 5 and 10 nm AgNP increased intracellular calcium levels. Remarkably, pre-treatment with quercetin conferred protection against almost all tested cytotoxic endpoints. However, quercetin failed to prevent total GSH loss and even exacerbated ATP depletion. Collectively, these findings provide the first integrated evidence of three sizes of AgNP-induced toxicity in human erythrocytes, demonstrating that quercetin confers broad, though not universal, protection. This underscores its potential as a modulator of nanoparticle-induced oxidative and metabolic damage.